Updated December 3 at 12:28am
Biotechnology
38 results total, viewing 21 - 30
Alexion Pharmaceuticals Inc. is planning a $200 million phased expansion of its manufacturing plant here, to facilitate production of its drug, Soliris, and other products. more
U.S. stocks rose for the first time since Britain voted to leave the European Union, rebounding amid optimism that policymakers are committed to limit the fallout from the U.K.’s exit. more
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
A five-year, $11.5 million grant from the National Institutes of Health will allow Brown University to launch the Center for Biomedical Research Excellence to study cancer, preeclampsia and severe lung infections. more
Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. more
Medtronic PLC, the largest maker of equipment to treat spinal conditions, agreed to help promote Mazor Robotics Ltd.’s guidance system used during spinal surgeries and will take an equity stake of up to 15 percent in the company. Mazor’s stock surged. more
Rhode Island ranked 33rd in the nation for venture-capital investment in the first quarter, which featured only one deal - $5 million to IlluminOss Medical Inc. more
(Updated 9:57 a.m. and 1:43 p.m.) Nabsys has completed a financial restructuring and is back in business, operating out of its Clifford Street office. more
« Prev | 1 | 2 | 3 | 4 Next »